| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | V5Q32BZX79 |
| InChI Key | UYGZODVVDUIDDQ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H23Cl2N3O3S |
| Molecular Weight | 468.41 |
| AlogP | 4.95 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 81.06 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 30.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group C
Nuclear hormone receptor subfamily 1 group C member 3
|
163 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus | 2 | D003920 | ClinicalTrials |
| Neuralgia, Postherpetic | 2 | D051474 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3545278 |
| DrugBank | DB12557 |
| FDA SRS | V5Q32BZX79 |
| SureChEMBL | SCHEMBL682052 |